Key Points
- Director Reginald Love sold 5,091 shares of Strata Critical Medical at an average price of $5.75, generating $29,273.25. His remaining stake totals 146,481 shares, a 3.36% reduction.
- SRTA shares opened at $5.97, with a market capitalization of approximately $516.6 million and a 12-month trading range of $3.85 to $6.50.
- Institutional investors own 47.36% of the company’s stock, while analysts maintain a consensus “Moderate Buy” rating with an $8.00 price target; Weiss Ratings downgraded its rating to “hold (c-).”
Strata Critical Medical (NASDAQ:SRTA - Get Free Report) Director Reginald Love sold 5,091 shares of Strata Critical Medical stock in a transaction on Monday, August 10th. The stock was sold at an average price of $5.75, for a total transaction of $29,273.25. Following the transaction, the director directly owned 146,481 shares of the company's stock, valued at $842,265.75. This represents a 3.36% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Strata Critical Medical Stock Down 1.0%
Shares of SRTA opened at $5.97 on Friday. The company has a market capitalization of $516.58 million, a PE ratio of -149.25 and a beta of 2.25. The firm's fifty day moving average price is $5.44. Strata Critical Medical has a 12 month low of $3.85 and a 12 month high of $6.50.
Hedge Funds Weigh In On Strata Critical Medical
Several institutional investors have recently made changes to their positions in SRTA. Seelaus Asset Management LLC boosted its position in shares of Strata Critical Medical by 32.7% during the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company's stock worth $102,000 after purchasing an additional 6,000 shares in the last quarter. Granite Investment Partners LLC grew its stake in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company's stock valued at $76,000 after buying an additional 7,911 shares during the period. Principal Financial Group Inc. bought a new stake in Strata Critical Medical in the 1st quarter valued at about $537,000. Dimensional Fund Advisors LP increased its position in Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company's stock valued at $6,759,000 after buying an additional 172,154 shares in the last quarter. Finally, Quantinno Capital Management LP raised its stake in Strata Critical Medical by 98.7% during the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company's stock worth $599,000 after buying an additional 71,155 shares during the period. Institutional investors and hedge funds own 47.36% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut Strata Critical Medical from a "hold (c)" rating to a "hold (c-)" rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Strata Critical Medical currently has a consensus rating of "Moderate Buy" and a consensus price target of $8.00.
View Our Latest Research Report on Strata Critical Medical
Strata Critical Medical Company Profile
(
Get Free Report)
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
